William Leenders PhD

Williams Leenders research concentrates on the generation of novel antibodies against specific markers which discriminate tumor- from normal tissue. We have particular interest in tumor blood vessels, as antibodies with specificity against tumor vessels can be utilized to immediately cut off the blood supply to tumors. Combinations of such targeted therapies with therapies that aim at the tumor cell itself, might dramatically improve current cancer treatment modalities which initially appeared promising, but ultimately turned out disappointing.